Mar 13 2008
Chromogenix factor X assay
In 1997, Moll and Ortel published a study concluding “lupus anticoagulants (LAs) can influence prothrombin times (PTs) and lead to INRs that do not accurately reflect the true level of [oral anticoagulant therapy (OAT)]. Use of the INR to standardize PTs is invalid for some patients with lupus anticoagulants. To prevent supratherapeutic or subtherapeutic anticoagulation, […]
read more